Articles
Injectable Drug Delivery Trends
How Global Trends Are Driving Patient-Centricity in Parenteral Products.
Parenteral products represent a major growth engine in today’s surging global biopharma market. Their share of...
Drug Research
Shoreline Launches into Era of Cell Therapy with $4 Billion in Partnerships
Shoreline Biosciences, an immunotherapy company formed in 2020 during the early days of the COVID-19 pandemic, was propelled into the proverbial catbird’s seat this...
Drug Research
Abveris and Abilita Bio Announce a Discovery Collaboration to Develop Therapeutics for Challenging Membrane Protein Targets
Abveris, Inc., and Abilita Bio, Inc., both privately held biotechnology companies, announce a joint research collaboration that will leverage the synergies between their platforms...
Drug Research
India’s first mRNA Covid vaccine by Gennova granted approval for Phase 2/3 clinical trails
India’s first mRNA-based COVID-19 vaccine candidate HGCO19 by Gennova Biopharmaceuticals Ltd has been granted approval for Phase 2/3 clinical trials, the Department of Biotechnology...
News
Sorrento’s Covid-19 vaccine induces robust immune responses in studies
Sorrento Therapeutics, Inc., a clinical and commercial stage biopharmaceutical company developing new therapies to treat cancer, pain and COVID-19. The publication details preclinical vaccination...
News
US FDA approves Jardiance to treat adults living with heart failure with reduced ejection fraction
Jardiance® (empagliflozin) 10 mg has been approved by the U.S. Food and Drug Administration to reduce the risk of cardiovascular death plus hospitalization for...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read